Related references
Note: Only part of the references are listed.Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
GASTROENTEROLOGY (2016)
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)
Vincent Leroy et al.
HEPATOLOGY (2016)
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis C virus relies on lipoproteins for its life cycle
Germana Grassi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Entry inhibitors: New advances in HCV treatment
Xi-Jing Qian et al.
EMERGING MICROBES & INFECTIONS (2016)
CD36 is a co-receptor for hepatitis C virus E1 protein attachment
Jun-Jun Cheng et al.
SCIENTIFIC REPORTS (2016)
Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection
Graham R. Foster et al.
GASTROENTEROLOGY (2015)
Sofosbuvir With Peginterferon-Ribavirin for 12 Weeks in Previously Treated Patients With Hepatitis C Genotype 2 or 3 and Cirrhosis
Eric Lawitz et al.
HEPATOLOGY (2015)
Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
Adeel A. Butt et al.
HEPATOLOGY (2015)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
Brian R. Edlin et al.
HEPATOLOGY (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Therapy for hepatitis C genotype 3: moving forward
M. Buti et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans
Yan Xu et al.
JOURNAL OF VIROLOGY (2015)
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
Jean-Michel Molina et al.
LANCET (2015)
Transcriptional regulation of hepatic lipogenesis
Yuhui Wang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus
Takasuke Fukuhara et al.
TRENDS IN MICROBIOLOGY (2015)
Hepatitis C virus and lipid droplets: finding a niche
Ana Filipe et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Hepatitis C virus infection: are there still specific problems with genotype 3?
Claire Gondeau et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Christophe Hezode et al.
GUT (2015)
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
Jane P. Messina et al.
HEPATOLOGY (2015)
Are statins a viable option for the treatment of infections with the hepatitis C virus?
Ben Verpaalen et al.
ANTIVIRAL RESEARCH (2014)
Molecular Mechanism of Regulation of the Atypical Protein Kinase C by N-terminal Domains and an Allosteric Small Compound
Hua Zhang et al.
CHEMISTRY & BIOLOGY (2014)
Oxysterol-Binding Protein Is a Phosphatidylinositol 4-Kinase Effector Required for HCV Replication Membrane Integrity and Cholesterol Trafficking
Hongliang Wang et al.
GASTROENTEROLOGY (2014)
Is Genotype 3 of the Hepatitis C Virus the New Villain?
Nicolas Goossens et al.
HEPATOLOGY (2014)
HCV Genotype 3 Is Associated With an Increased Risk of Cirrhosis and Hepatocellular Cancer in a National Sample of US Veterans With HCV
Fasiha Kanwal et al.
HEPATOLOGY (2014)
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
Mark S. Sulkowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Modulation of Triglyceride and Cholesterol Ester Synthesis Impairs Assembly of Infectious Hepatitis C Virus
Jolanda M. P. Liefhebber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Biogenesis of the multifunctional lipid droplet: Lipids, proteins, and sites
Albert Pol et al.
JOURNAL OF CELL BIOLOGY (2014)
Virology and cell biology of the hepatitis C virus life cycle - An update
Jean Dubuisson et al.
JOURNAL OF HEPATOLOGY (2014)
Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study
Mark S. Sulkowski et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Modulation of Hepatitis C Virus Genome Replication by Glycosphingolipids and Four-Phosphate Adaptor Protein 2
Irfan Khan et al.
JOURNAL OF VIROLOGY (2014)
Stearoyl Coenzyme A Desaturase 1 Is Associated with Hepatitis C Virus Replication Complex and Regulates Viral Replication
Lam N. Nguyen et al.
JOURNAL OF VIROLOGY (2014)
Involvement of Hepatitis C Virus NS5A Hyperphosphorylation Mediated by Casein Kinase I-α in Infectious Virus Production
Takahiro Masaki et al.
JOURNAL OF VIROLOGY (2014)
Scavenger Receptor class B type I (SR-BI): A versatile receptor with multiple functions and actions
Wen-Jun Shen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein
Mathieu Lefevre et al.
PLOS ONE (2014)
HCV 3a Core Protein Increases Lipid Droplet Cholesteryl Ester Content via a Mechanism Dependent on Sphingolipid Biosynthesis
Ursula Loizides-Mangold et al.
PLOS ONE (2014)
The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C Results From an Analysis of Data From a Department of Veterans Affairs Clinical Registry
Jeffrey McCombs et al.
JAMA INTERNAL MEDICINE (2014)
Approaches to hepatitis C treatment and cure using NS5A inhibitors
James J. Kohler et al.
INFECTION AND DRUG RESISTANCE (2014)
Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885
Kelly A. Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Hepatoma polarization limits CD81 and hepatitis C virus dynamics
H. J. Harris et al.
CELLULAR MICROBIOLOGY (2013)
EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry
Julie Potel et al.
CELLULAR MICROBIOLOGY (2013)
Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III
Hung-Yu Sun et al.
GUT (2013)
The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination
Muhammad N. Zahid et al.
HEPATOLOGY (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism
Marion Peyrou et al.
JOURNAL OF HEPATOLOGY (2013)
Syndecan-1 Serves as the Major Receptor for Attachment of Hepatitis C Virus to the Surfaces of Hepatocytes
Qing Shi et al.
JOURNAL OF VIROLOGY (2013)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Ching-Sheng Hsu
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors
Jieyun Jiang et al.
PLOS ONE (2013)
Ultrastructural analysis of hepatitis C virus particles
Maria Teresa Catanese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of transferrin receptor 1 as a hepatitis C virus entry factor
Danyelle N. Martin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Clinical response to statins: Mechanism(s) of variable activity and adverse effects
Cesare R. Sirtori et al.
ANNALS OF MEDICINE (2012)
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner
Paul J. Clark et al.
HEPATOLOGY (2012)
High Sustained Virologic Response Rates in Rapid Virologic Response Patients in the Large Real-World PROPHESYS Cohort Confirm Results From Randomized Clinical Trials
Patrick Marcellin et al.
HEPATOLOGY (2012)
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
Viet Loan Dao Thi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
Mei-Hsuan Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin
C. Kondo et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Bruno Sainz et al.
NATURE MEDICINE (2012)
SREBPs: metabolic integrators in physiology and metabolism
Tae-Il Jeon et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity
Annalisa Bianco et al.
PLOS PATHOGENS (2012)
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
Ines Romero-Brey et al.
PLOS PATHOGENS (2012)
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Lin Jia et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment
Simon Reiss et al.
CELL HOST & MICROBE (2011)
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States
David B. Rein et al.
DIGESTIVE AND LIVER DISEASE (2011)
Down-Regulation of Phosphatase and Tensin Homolog by Hepatitis C Virus Core 3a in Hepatocytes Triggers the Formation of Large Lipid Droplets
Sophie Clement et al.
HEPATOLOGY (2011)
Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
Andreas Merz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hepatitis C Virus Core Protein Decreases Lipid Droplet Turnover A MECHANISM FOR CORE-INDUCED STEATOSIS
Charles Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Andrew J. Syder et al.
JOURNAL OF HEPATOLOGY (2011)
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C
K. Patel et al.
JOURNAL OF VIRAL HEPATITIS (2011)
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
G. Nkontchou et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis
A. Probst et al.
JOURNAL OF VIRAL HEPATITIS (2011)
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger et al.
NATURE MEDICINE (2011)
CD36 as a lipid sensor
Celine Martin et al.
PHYSIOLOGY & BEHAVIOR (2011)
Unique ties between hepatitis C virus replication and intracellular lipids
Eva Herker et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
An overview of HCV molecular biology, replication and immune responses
Usman A. Ashfaq et al.
VIROLOGY JOURNAL (2011)
Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1
Zhonghua Xiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Apolipoprotein E Interacts with Hepatitis C Virus Nonstructural Protein 5A and Determines Assembly of Infectious Particles
Wagane J. A. Benga et al.
HEPATOLOGY (2010)
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Helen J. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway
Candice Jackel-Cram et al.
JOURNAL OF GENERAL VIROLOGY (2010)
In vivo effects of fluvastatin on HCV replication in HIV-1 coinfected subjects
L. Milazzo et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms
Takayuki Hishiki et al.
JOURNAL OF VIROLOGY (2010)
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
Eva Herker et al.
NATURE MEDICINE (2010)
The SR-BI Partner PDZK1 Facilitates Hepatitis C Virus Entry
Nicholas S. Eyre et al.
PLOS PATHOGENS (2010)
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
David Masson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
Karla F. Leavens et al.
CELL METABOLISM (2009)
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
Hitomi Sezaki et al.
INTERVIROLOGY (2009)
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients
L. Milazzo et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
Jieyun Jiang et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Do statins reduce hepatitis C RNA titers during routine clinical use?
Kimberly A. Forde et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2
Jae-Ku Oem et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Apolipoprotein C1 association with hepatitis C virus
Jean-Christophe Meunier et al.
JOURNAL OF VIROLOGY (2008)
CD81 and claudin 1 coreceptor association: Role in hepatitis C virus entry
Helen J. Harris et al.
JOURNAL OF VIROLOGY (2008)
Interaction of hepatitis c virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles
Takahiro Masaki et al.
JOURNAL OF VIROLOGY (2008)
Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly
Nicole Appel et al.
PLOS PATHOGENS (2008)
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion
Pablo Gastaminza et al.
JOURNAL OF VIROLOGY (2008)
A patient with gallbladder cancer with paraaortic lymph node and hepatic metastases who has survived for more than 13 years after the primary extended radical operation
Takeshi Amemiya et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture
Kyung-Soo Chang et al.
JOURNAL OF VIROLOGY (2007)
The lipid droplet is an important organelle for hepatitis C virus production
Yusuke Miyanari et al.
NATURE CELL BIOLOGY (2007)
被撤回的出版物: Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress (Retracted article. See vol. 94, 2020)
Gularn Waris et al.
JOURNAL OF VIROLOGY (2007)
Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: Genotype-3a core has a stronger effect than genotype-1b core
Candice Jackel-Cram et al.
JOURNAL OF HEPATOLOGY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial
Jacqueline G. O'Leary et al.
HEPATOLOGY (2007)
Structural and mechanistic insights into hepatitis C viral translation initiation
Christopher S. Fraser et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Hepatitis C virus entry depends on clathrin-mediated endocytosis
Emmanuelle Blanchard et al.
JOURNAL OF VIROLOGY (2006)
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients
SU Nielsen et al.
JOURNAL OF VIROLOGY (2006)
An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation
K Abid et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
SB Kapadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft
L Gao et al.
JOURNAL OF VIROLOGY (2004)
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
MJ Evans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons
R Gosert et al.
JOURNAL OF VIROLOGY (2003)
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that coffactionates with caveolin-2
ST Shi et al.
JOURNAL OF VIROLOGY (2003)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
P André et al.
JOURNAL OF VIROLOGY (2002)
Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex
D Egger et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
